Skip to main content

Featured

  Money Dates | Canadian Money Brief What's Paid, Due or Changing This Week Week of Monday, November 16, 2026 Three dates matter this week: a big inflation report on Monday, then two benefit payments on Thursday and Friday. Here is the week, plus what is coming over the next five weeks. This Week: Nov 16 to 22 Date What What to know Mon, Nov 16 8:30 am ET October inflation report (CPI) Statistics Canada's CPI for October. September came in at 3.1%, up from 3.0% in August. The Bank of Canada watches this before its Dec 9 decision. Thu, Nov 19 Canada Disability Benefit Up to $204.20 a month. Paid on the third Thursday of each month. Fri, Nov 20 Canada Child Benefit (CCB) Up to $679.75 a month for each child under 6 and $573.58 for each child aged 6 to 17, for families under the income threshold. Not this week: CPP and OAS (Nov 26). The Groceries and Essentials Benefit, formerly the GST/HST credit, is not paid again until Jan 5, 2027. The Ontario Trillium Benefit was paid Nov 10....

article

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Comments